HC relief for 14 more drug firms
Unlock Exclusive Insights with The Tribune Premium
Take your experience further with Premium access. Thought-provoking Opinions, Expert Analysis, In-depth Insights and other Member Only BenefitsNew Delhi, March 17
Fourteen more healthcare majors, including Cipla, Lupin, Wockhardt, Glaxosmithkline and Mankind Pharma, were today granted interim relief by the Delhi High Court, which stayed till March 21 the ban imposed by the Centre on sale of some of their fixed dose combination (FDC) drugs.
Apart from these five, Justice Rajiv Sahai Endlaw also provided relief to Dr Reddy’s, Laborate Pharmaceuticals, Alkem Laboratories, Ajanta Pharma, Khandelwal Laboratories Pvt Ltd, Micro Lab Ltd, FDC Ltd, Coral Laboratories Ltd and Eris Lifesciences Pvt Ltd.
The court passed the same order as was issued in the pleas filed by the eight other companies, including Pfizer, Procter and Gamble (P&G), Glenmark and Reckitt Benckiser in the past three days.
“The same order. We will hear on Monday (March 21),” the court said and added that government should file its affidavit before that date.
Till date, the interim stay order of the high court is being enjoyed by 22 companies which also include Abbott Healthcare, Alembic, Piramal Enterprises and Macleods Pharma. — PTI
